---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-033195"
form_type: "8-K"
ticker: "SBC"
cik: "0001930313"
company_name: "SBC Medical Group Holdings Inc"
filed_at: "2026-07-14T21:00:30+00:00"
generated_at: "2026-07-14T21:02:11.691862+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# SBC Medical loses Nasdaq compliance after director departure; cure period granted

## Summary
- Director Mike Sayama did not seek re-election, leaving board with 2 of 4 independent directors and audit committee with 2 members.
- Nasdaq granted cure period until earlier of next annual meeting or July 9, 2027; company searching for a fifth independent director.
- Shareholders approved charter amendments: eliminate plurality voting, remove for-cause removal, opt out of DGCL Section 203, and officer exculpation.
- Bylaws amended to incorporate universal proxy rules, update quorum, and enhance advance notice provisions for stockholder nominations.
- All four director nominees elected with over 90 million votes each; ratification of auditor MaloneBailey approved.

## SEC filing metadata
- accession: 0001493152-26-033195
- form_type: 8-K
- ticker: SBC
- cik: 0001930313
- company_name: SBC Medical Group Holdings Inc
- filed_at: 2026-07-14T21:00:30+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.01, 3.03, 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1930313/000149315226033195/0001493152-26-033195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1930313/000149315226033195/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-033195
- JSON: https://secwatch.observer/filing/0001493152-26-033195.json
- Plain text: https://secwatch.observer/filing/0001493152-26-033195.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.